HomeCompareAVCTF vs ADC

AVCTF vs ADC: Dividend Comparison 2026

AVCTF yields 230.65% · ADC yields 4.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AVCTF wins by $279.04M in total portfolio value
10 years
AVCTF
AVCTF
● Live price
230.65%
Share price
$0.87
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$279.22M
Annual income
$150,694,330.53
Full AVCTF calculator →
ADC
Agree Realty Corporation
● Live price
4.13%
Share price
$74.97
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$178.9K
Annual income
$80,797.29
Full ADC calculator →

Portfolio growth — AVCTF vs ADC

📍 AVCTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAVCTFADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AVCTF + ADC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AVCTF pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVCTF
Annual income on $10K today (after 15% tax)
$19,605.58/yr
After 10yr DRIP, annual income (after tax)
$128,090,180.95/yr
ADC
Annual income on $10K today (after 15% tax)
$351.36/yr
After 10yr DRIP, annual income (after tax)
$68,677.70/yr
At 15% tax rate, AVCTF beats the other by $128,021,503.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVCTF + ADC for your $10,000?

AVCTF: 50%ADC: 50%
100% ADC50/50100% AVCTF
Portfolio after 10yr
$139.70M
Annual income
$75,387,563.91/yr
Blended yield
53.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

AVCTF
Analyst Ratings
1
Sell
Consensus: Sell
Altman Z
-7.0
Piotroski
3/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+8.1% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVCTF buys
0
ADC buys
0
No recent congressional trades found for AVCTF or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAVCTFADC
Forward yield230.65%4.13%
Annual dividend / share$2.00$3.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$279.22M$178.9K
Annual income after 10y$150,694,330.53$80,797.29
Total dividends collected$265.09M$156.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusSellBuy

Year-by-year: AVCTF vs ADC ($10,000, DRIP)

YearAVCTF PortfolioAVCTF Income/yrADC PortfolioADC Income/yrGap
1← crossover$33,765$23,065.39$10,990$580.36+$22.8KAVCTF
2$108,915$72,786.16$12,301$860.26+$96.6KAVCTF
3$335,962$219,422.65$14,104$1,298.62+$321.9KAVCTF
4$992,036$632,556.65$16,691$2,008.16+$975.3KAVCTF
5$2,807,112$1,745,633.43$20,580$3,205.09+$2.79MAVCTF
6$7,619,990$4,616,380.77$26,754$5,330.02+$7.59MAVCTF
7$19,864,891$11,711,501.13$37,196$9,345.14+$19.83MAVCTF
8$49,789,295$28,533,861.41$56,244$17,523.09+$49.73MAVCTF
9$120,113,025$66,838,479.41$94,286$35,736.21+$120.02MAVCTF
10$279,215,267$150,694,330.53$178,949$80,797.29+$279.04MAVCTF

AVCTF vs ADC: Complete Analysis 2026

AVCTFStock

Avacta Group Plc, a clinical stage biopharmaceutical company, develops cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms in the United Kingdom, North America, South Korea, and rest of Asia and Europe. It operates through Diagnostics and Therapeutics segments. The company develops custom Affimer proteins for customer products and in-house diagnostic assays. It also develops AffiDX SARS-CoV-2 lateral flow rapid antigen tests, as well as Affimer reagents for third party products; and novel cancer immunotherapies combining proprietary platforms. The company has a research collaboration with pre|CISION technology incorporates a substrate that is sensitive to cleavage by fibroblast activation protein alpha; drug development collaboration with LG Chem Life Sciences; partnership with Tufts University School of Medicine for developing Affimer drug conjugate therapies; licensing agreement with POINT Biopharma Inc. for the development of tumour activated radiopharmaceuticals; and drug development partnership with AffyXell to develop engineered mesenchymal stem cells to treat autoimmune diseases. Avacta Group Plc was incorporated in 2003 and is based in Wetherby, the United Kingdom.

Full AVCTF Calculator →

ADCREIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this AVCTF vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVCTF vs SCHDAVCTF vs JEPIAVCTF vs OAVCTF vs KOAVCTF vs MAINAVCTF vs NNNAVCTF vs EPRTAVCTF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.